[{"address1": "Royal Bank Plaza", "address2": "Suite 2800 South Tower 200 Bay Street", "city": "Toronto", "state": "ON", "zip": "M5J 2J1", "country": "Canada", "phone": "647-660-1780", "website": "https://satellos.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of duchenne. The company's MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Francis  Gleeson B.B.A. M.B.A", "age": 68, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 590109, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Williams CA, CPA", "age": 45, "title": "CFO & Corporate Secretary", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 249539, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Lambert M.A., Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 630872, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Cross M.B.A., Ph.D.", "age": 58, "title": "Chief Business Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 252423, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Rudnicki Ph.D.", "age": 61, "title": "Co-Founder & Chief Discovery Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 87528, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. J. Robert Hall CFA", "title": "Senior Vice President of Finance & Administration", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ryan  Mitchell Ph.D.", "title": "Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William Wasyl Jarosz", "age": 67, "title": "Executive Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 141350, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Desiree  Chan", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Courtney  Wells", "title": "Senior Vice President of Clinical Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.3407, "open": 0.33, "dayLow": 0.33, "dayHigh": 0.3437, "regularMarketPreviousClose": 0.3407, "regularMarketOpen": 0.33, "regularMarketDayLow": 0.33, "regularMarketDayHigh": 0.3437, "beta": 1.092, "forwardPE": -3.3009999, "volume": 15017, "regularMarketVolume": 15017, "averageVolume": 16651, "averageVolume10days": 18550, "averageDailyVolume10Day": 18550, "marketCap": 37232640, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 0.57, "fiftyDayAverage": 0.42266, "twoHundredDayAverage": 0.3589, "currency": "USD", "enterpriseValue": -2354473, "floatShares": 88567394, "sharesOutstanding": 112792000, "heldPercentInsiders": 0.17558001, "heldPercentInstitutions": 0.0088599995, "impliedSharesOutstanding": 115044000, "bookValue": 0.361, "priceToBook": 0.91440445, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -15889000, "trailingEps": -0.13, "forwardEps": -0.1, "lastSplitFactor": "1:20", "lastSplitDate": 1629244800, "enterpriseToEbitda": 0.152, "52WeekChange": -0.3877551, "SandP52WeekChange": 0.21080327, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "MSCLF", "underlyingSymbol": "MSCLF", "shortName": "SATELLOS BIOSCIENCE INC", "longName": "Satellos Bioscience Inc.", "firstTradeDateEpochUtc": 1344000600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "48842655-835e-3cc4-bfca-60f3fe40b54a", "messageBoardId": "finmb_650365067", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.3301, "targetHighPrice": 1.01, "targetLowPrice": 1.01, "targetMeanPrice": 1.01, "targetMedianPrice": 1.01, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 39587000, "totalCashPerShare": 0.351, "ebitda": -15456000, "quickRatio": 11.084, "currentRatio": 11.126, "returnOnAssets": -0.38277, "returnOnEquity": -0.72152, "freeCashflow": -7249000, "operatingCashflow": -14501000, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-04-26"}]